Legal Opinion

Mylan Pharmaceuticals Inc v. Warner Chilcott Public Limited

Court of Appeals for the Third Circuit

Decided September 28, 2016No. 15-2236PublishedCited by 24 opinions

1Opinion of the Court

OPINION OF THE COURT

FUENTES, Circuit Judge.

Mylan Pharmaceuticals, Inc., a generic drug manufacturer, and several other Plaintiffs (hereinafter “Mylan”) originally brought this action against Defendants, Warner Chilcott and Mayne Pharma, both name-brand drug manufacturers. Defendants manufacture and sell “Doryx,” the name-brand version of delayed-release doxycycline hyclate, an oral antibiotic of the tetracycline class used to treat severe acne. Tetracyclines are a broad category of antibiotics, the most common being doxy-cycline monohydrate and minocycline, which vary in their use and…

2Cases cited29 opinions

  1. Matsushita Electric Industrial Co., Ltd. v. Zenith Radio CorporationSupreme Court of the United States · 1986
  2. United States v. Grinnell Corp.Supreme Court of the United States · 1966
  3. Brown Shoe Co. v. United StatesSupreme Court of the United States · 1962
  4. Eastman Kodak Co. v. Image Technical Services, Inc.Supreme Court of the United States · 1992
  5. Jefferson Parish Hospital District No. 2 v. HydeSupreme Court of the United States · 1984

24 more not listed; retrieve them via the Exa API.

3Cited by24 opinions

  1. Federal Trade Commission v. AbbVie IncCourt of Appeals for the Third Circuit · 2020
  2. Philadelphia Taxi Association v. Uber Technologies IncCourt of Appeals for the Third Circuit · 2018
  3. Lifewatch Services Inc v. Highmark IncCourt of Appeals for the Third Circuit · 2018
  4. In re: Suboxone Antitrust v.Court of Appeals for the Third Circuit · 2020
  5. United Food & Commercial Workers Local 1776 & Participating Emp'rs Health & Welfare Fund v. Teikoku Pharma United StatesDistrict Court, N.D. California · 2017

19 more not listed; retrieve them via the Exa API.

Showing a preview — retrieve the full document via the Exa API.

Powered by the Exa API